Vibrational spectroscopy modeling of a drug in molecular solvents and enzymes
© 2017 Elsevier B.V. Modeling of drugs in enzymes is of immensurable value to many areas of science. We present a theoretical study on the vibrational spectroscopy of Rilpivirine, a HIV reverse transcriptase inhibitor, in conventional solvents and in clinically relevant enzymes. The study is based on vibrational spectroscopy modeling of the drug using molecular dynamics simulations, DFT frequency maps, and theory. The modeling of the infrared lineshape shows good agreement with experimental data for the drug in molecular solvents where the local environment motions define the vibrational band lineshape. On the other hand, the theoretical description of the drug in the different enzymes does not match previous experimental findings indicating that the utilized methodology might not apply to heterogeneous environments. Our findings show that the lack of reproducibility might be associated with the development of the frequency map which does not contain all of the possible interactions observed in such systems.
Publication Source (Journal or Book title)
Devereux, C., Fulfer, K., Zhang, X., & Kuroda, D. (2017). Vibrational spectroscopy modeling of a drug in molecular solvents and enzymes. Chemical Physics, 495, 1-9. https://doi.org/10.1016/j.chemphys.2017.08.002